Verena Kalter
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.
Journal: Nature communications
Published: June 19, 2023
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients.
Journal: Leukemia
Published: January 28, 2021
Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity.
Journal: Immunity
Published: January 09, 2021
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
Journal: Cell
Published: December 16, 2019
IGF2 knockdown in two colorectal cancer cell lines decreases survival, adhesion and modulates survival-associated genes.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: October 02, 2015
Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
Journal: Leukemia
Published: April 16, 2015
CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation.
Journal: Journal of cancer research and clinical oncology
Published: March 17, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026